参考文献/References:
[1]Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.[2]Babjuk M,Burger M,Capoun O,et al.European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)[J].Eur Urol,2022,81(1):75-94.[3]Gontero P,Sylvester R,Pisano F,et al.Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients[J]. Eur Urol,2015,67(1):74-82.[4]Hussain SA,Lester JF,Jackson R,et al.Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE):a double-blind,randomised,phase 2 trial[J].Lancet Oncol,2022,23(5):650-658.[5]Diakos CI,Charles KA,McMillan DC,et al.Cancer-related inflammation and treatment effectiveness[J].Lancet Oncol,2014,15(11):e493-e503.[6]Templeton AJ,McNamara MG,?譒eruga B,et al.Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis[J].J Natl Cancer Inst,2014,106(6):dju124.[7]Wen S,Chen N,Hu Y,et al.Elevated peripheral absolute monocyte count related to clinicopathological features and poor prognosis in solid tumors: Systematic review, meta-analysis, and meta-regression[J].Cancer Med,2021,10(5):1690-1714.[8]Wu M,Yang S,Feng X,et al.Prognostic value of the postoperative neutrophil-lymphocyte ratio in solid tumors: A meta-analysis[J].PLoS One,2021,16(4):e0250091.[9]Chung JW,Park DJ,Chun SY,et al.The prognostic role of preoperative serum albumin/globulin ratio in patients with non-metastatic renal cell carcinoma undergoing partial or radical nephrectomy[J].Sci Rep,2020,10(1):11999.[10]Guo HW,Yuan TZ,Chen JX,et al.Prognostic value of pretreatment albumin/globulin ratio in digestive system cancers: A meta-analysis[J].PLoS One,2018,13(1):e0189839.[11]Ma JY,Liu G,Pan LZ,et al.Clinical impact of pretreatment albumin-globulin ratio in patients with colorectal cancer: A meta-analysis[J].Medicine (Baltimore),2022,101(20):e29190.[12]Stang A.Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses[J].Eur J Epidemiol,2010,25(9):603-605.[13]Liu J,Dai Y,Zhou F,et al.The prognostic role of preoperative serum albumin/globulin ratio in patients with bladder urothelial carcinoma undergoing radical cystectomy[J].Urol Oncol,2016,34(11):484.e1-484.e8.[14]Liu Z,Huang H,Li S,et al.The prognostic value of preoperative serum albumin-globulin ratio for high-grade bladder urothelial carcinoma treated with radical cystectomy: A propensity score-matched analysis[J].J Cancer Res Ther,2017,13(5):837-843.[15]Niwa N,Matsumoto K,Ide H,et al.Prognostic Value of Pretreatment Albumin-to-Globulin Ratio in Patients With Non-Muscle-Invasive Bladder Cancer[J].Clin Genitourin Cancer,2018,16(3):e655-e661.[16]张景波,韩博,安瑞华.术前白蛋白/球蛋白比值在非肌层浸润性膀胱癌患者预后评估中的价值[J].现代泌尿外科杂志,2019,24(4):275-279.[17]Schuettfort VM,D Andrea D,Quhal F,et al.Impact of preoperative serum albumin-globulin ratio on disease outcome after radical cystectomy for urothelial carcinoma of the bladder[J].Urol Oncol,2021,39(4):235.e5-235.e14.[18]Oh JS,Park DJ,Byeon KH,et al.Decrease of Preoperative Serum Albumin-to-Globulin Ratio as a Prognostic Indicator after Radical Cystectomy in Patients with Urothelial Bladder Cancer[J].Urol J,2021,18(1):66-73.[19]Quhal F,Pradere B,Laukhtina E,et al.Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer[J].World J Urol,2021,39(9):3345-3352.[20]Wang K,Gu Y,Ni J,et al.Combination of Total Psoas Index and Albumin-Globulin Score for the Prognosis Prediction of Bladder Cancer Patients After Radical Cystectomy: A Population-Based Study[J].Front Oncol,2021,11:724536.[21]Zhang W,Yang F,Kadier A,et al.Development of nomograms related to in?ammatory biomarkers to estimate the prognosis of bladder cancer after radical cystectomy[J].Ann Transl Med,2021,9(18):1440.[22]Fujiya K,Kawamura T,Omae K,et al.Impact of Malnutrition After Gastrectomy for Gastric Cancer on Long-Term Survival[J].Ann Surg Oncol,2018,25(4):974-983.[23]He J,Pan H,Liang W,et al.Prognostic Effect of Albumin-to-Globulin Ratio in Patients with solid tumors: A Systematic Review and Meta-analysis[J].J Cancer,2017,8(19):4002-4010.[24]McMillan DC,Watson WS,O’Gorman P,et al.Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss[J].Nutr Cancer,2001,39(2):210-213.[25]Wigner P,Gr?誰bowski R,Bijak M,et al.The Interplay between Oxidative Stress, Inflammation and Angiogenesis in Bladder Cancer Development[J].Int J Mol Sci,2021,22(9):4483.[26]Soeters PB,Wolfe RR,Shenkin A.Hypoalbuminemia: Pathogenesis and Clinical Significance[J].JPEN J Parenter Enteral Nutr,2019,43(2):181-193.[27]Kamphorst JJ,Nofal M,Commisso C,et al.Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein[J].Cancer Res,2015,75(3):544-553.[28]Anraku M,Shintomo R,Taguchi K,et al.Amino acids of importance for the antioxidant activity of human serum albumin as revealed by recombinant mutants and genetic variants[J].Life Sci,2015,134:36-41.[29]Chuang YH,Wang YH,Chang TK,et al.Albumin acts like transforming growth factor β1 in microbubble-based drug delivery[J].Ultrasound Med Biol,2014,40(4):765-774.[30]Gupta D,Lis CG.Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature[J].Nutr J,2010,9:69.[31]Chen J,Zhou Y,Xu Y,et al.Low pretreatment serum globulin may predict favorable prognosis for gastric cancer patients[J].Tumour Biol,2016,37(3):3905-3911.[32]Suh B,Park S,Shin DW,et al.Low albumin-to-globulin ratio associated with cancer incidence and mortality in generally healthy adults[J].Ann Oncol,2014,25(11):2260-2266.[33]Miura N,Mori K,Laukhtina E,et al.Prognostic value of the preoperative albumin-globulin ratio in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration[J].Jpn J Clin Oncol,2021,51(7):1149-1157.[34]Lv GY,An L,Sun XD,et al.Pretreatment albumin to globulin ratio can serve as a prognostic marker in human cancers: a meta-analysis[J].Clin Chim Acta,2018,476:81-91.
相似文献/References:
[1]幸世玉.经尿道电切术联合吉西他滨灌注治疗膀胱癌的临床效果分析[J].医学信息,2018,31(20):91.[doi:10.3969/j.issn.1006-1959.2018.20.026]
XING Shi-yu.Clinical Analysis of Transurethral Resection Combined with Gemcitabine Perfusion in the Treatment of Bladder Cancer[J].Journal of Medical Information,2018,31(20):91.[doi:10.3969/j.issn.1006-1959.2018.20.026]
[2]熊波波,张劲松,王海峰,等.miRNAs与泌尿系肿瘤关系的研究进展[J].医学信息,2019,32(05):35.[doi:10.3969/j.issn.1006-1959.2019.04.013]
XIONG Bo-bo,ZHANG Jin-song,WANG Hai-feng,et al.Research Progress on the Relationship between miRNAs and Urinary Tumors[J].Journal of Medical Information,2019,32(20):35.[doi:10.3969/j.issn.1006-1959.2019.04.013]
[3]杜国望,陈 昊,苗岳松,等.保留膀胱综合疗法治疗肌层浸润性膀胱癌的效果[J].医学信息,2020,33(06):122.[doi:10.3969/j.issn.1006-1959.2020.06.038]
DU Guo-wang,CHEN Hao,MIAO Yue-song,et al.Effect of Bladder-preserving Comprehensive Therapy on Muscular Invasive Bladder Cancer[J].Journal of Medical Information,2020,33(20):122.[doi:10.3969/j.issn.1006-1959.2020.06.038]
[4]张晓伟,陈 明,田谋利,等.术中体位变化和气腹对机器人辅助腹腔镜根治性膀胱切除患者眼压的影响[J].医学信息,2020,33(14):113.[doi:10.3969/j.issn.1006-1959.2020.14.034]
ZHANG Xiao-wei,CHEN Ming,TIAN Mou-li,et al.Effects of Intraoperative Posture Changes and Pneumoperitoneum on Intraocular Pressure in Patients with Robot-assisted Laparoscopic Radical Cystectomy[J].Journal of Medical Information,2020,33(20):113.[doi:10.3969/j.issn.1006-1959.2020.14.034]
[5]孙祖刚,王咸钟,谢习颂,等.慢性炎症分子基础及信号通路在膀胱癌中的作用[J].医学信息,2020,33(19):31.[doi:10.3969/j.issn.1006-1959.2020.19.010]
SUN Zu-gang,WANG Xian-zhong,XIE Xi-song,et al.The Molecular Basis of Chronic Inflammation and the Role of Signal Pathways in Bladder Cancer[J].Journal of Medical Information,2020,33(20):31.[doi:10.3969/j.issn.1006-1959.2020.19.010]
[6]熊 雄,熊 斌,姚 烽.CYFRA21-1与BTA stat检测在膀胱癌诊断中的应用价值[J].医学信息,2020,33(22):104.[doi:10.3969/j.issn.1006-1959.2020.22.029]
XIONG Xiong,XIONG Bin,YAO Feng.Application Value of CYFRA21-1 and BTA Stat in the Diagnosis of Bladder Cancer[J].Journal of Medical Information,2020,33(20):104.[doi:10.3969/j.issn.1006-1959.2020.22.029]
[7]郝保良.等离子针状电极剜切治疗非肌层浸润性膀胱癌的效果[J].医学信息,2021,34(04):148.[doi:10.3969/j.issn.1006-1959.2021.04.040]
HAO Bao-liang.Effect Plasma Needle Electrode Enucleation for Non-muscular Invasive Carcinoma of Urinary Bladder[J].Journal of Medical Information,2021,34(20):148.[doi:10.3969/j.issn.1006-1959.2021.04.040]
[8]苗岳松,刘 杰,刘 昕,等.循环肿瘤细胞在膀胱癌诊疗中的应用价值[J].医学信息,2021,34(08):72.[doi:10.3969/j.issn.1006-1959.2021.08.019]
MIAO Yue-song,LIU Jie,LIU Xin,et al.The Application Value of Circulating Tumor Cells in the Diagnosis and Treatment of Bladder Cancer[J].Journal of Medical Information,2021,34(20):72.[doi:10.3969/j.issn.1006-1959.2021.08.019]
[9]刘 坤,陈德春.基于生信学方法分析GSDM基因家族在膀胱癌的表达及临床意义[J].医学信息,2022,35(10):14.[doi:10.3969/j.issn.1006-1959.2022.10.003]
LIU Kun,CHEN De-chun.Expression and Clinical Significance of GSDM Gene Family in Bladder Cancer Based on Bioinformatics Analysis[J].Journal of Medical Information,2022,35(20):14.[doi:10.3969/j.issn.1006-1959.2022.10.003]
[10]任默涵,于东海,吴 迪.MTHFD2基因在膀胱癌中的表达、功能富集及信号通路的生物信息学分析[J].医学信息,2022,35(24):18.[doi:10.3969/j.issn.1006-1959.2022.24.004]
REN Mo-han,YU Dong-hai,WU Di.Expression, Functional Enrichment and Bioinformatics Analysis of MTHFD2 Gene in Bladder Cancer[J].Journal of Medical Information,2022,35(20):18.[doi:10.3969/j.issn.1006-1959.2022.24.004]